Literature DB >> 20888651

Low triiodothyronine and exercise capacity in heart failure.

Marianna Fontana1, Claudio Passino, Roberta Poletti, Luc Zyw, Concetta Prontera, Maria Scarlattini, Aldo Clerico, Michele Emdin, Giorgio Iervasi.   

Abstract

BACKGROUND: Cardiopulmonary exercise test (CPT) has a prominent value in assessing clinical severity in chronic heart failure (HF) patients. Reduced free triiodothyronine (fT3) plasma level is associated with a more severe disease and prognosis. The aim of this study was to evaluate the relationship between low fT3 plasma level and reduced exercise capacity in chronic HF, and to determine the influence of a low T3 status in subsets of patients with different functional impairment. METHODS AND
RESULTS: 240 HF patients (79% males; age 62 ± 12 years, mean ± standard deviation; left ventricular ejection fraction, EF, 30 ± 9%) underwent a CPT, clinical and neurohormonal characterization (assay for plasma brain natriuretic peptide, BNP, norepinephrine, aldosterone, renin activity, fT3, free T4, thyroid-stimulating hormone). At multivariate analysis in the whole population, age, gender and BNP level were independently associated with peak VO2, whereas in patients with severe functional impairment (peak VO2 < 14 ml/min/kg) fT3 resulted independently related to peak VO2, together with gender and BNP. When patients with peak VO2 < 14 ml/min/kg were divided according to fT3 levels, patients with low T3 syndrome showed reduced exercise capacity and worse ventilatory efficiency.
CONCLUSIONS: BNP and fT3 are independently associated with exercise capacity in severely compromised HF patients.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20888651     DOI: 10.1016/j.ijcard.2010.09.002

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  6 in total

Review 1.  Translating thyroid hormone effects into clinical practice: the relevance of thyroid hormone receptor α1 in cardiac repair.

Authors:  Constantinos Pantos; Iordanis Mourouzis
Journal:  Heart Fail Rev       Date:  2015-05       Impact factor: 4.214

2.  Ischemic stroke functional outcomes are independently associated with C-reactive protein concentrations and cognitive outcomes with triiodothyronine concentrations: a pilot study.

Authors:  Adomas Bunevicius; Henrikas Kazlauskas; Nijole Raskauskiene; Vinsas Janusonis; Robertas Bunevicius
Journal:  Endocrine       Date:  2013-04-21       Impact factor: 3.633

3.  Serum thyroid-stimulating hormone levels are not associated with exercise capacity and lung function parameters in two population-based studies.

Authors:  Till Ittermann; Sven Gläser; Ralf Ewert; Stephan Felix; Henry Völzke; Marcus Dörr
Journal:  BMC Pulm Med       Date:  2014-09-02       Impact factor: 3.317

4.  Pulmonary consequences of hypothyroidism.

Authors:  Samiaa Hamdy Sadek; Walaa Anwar Khalifa; Ahmad Metwally Azoz
Journal:  Ann Thorac Med       Date:  2017 Jul-Sep       Impact factor: 2.219

5.  Modified Low-Dose Triiodo-L-thyronine Therapy Safely Improves Function Following Myocardial Ischemia-Reperfusion Injury.

Authors:  Viswanathan Rajagopalan; Youhua Zhang; Christine Pol; Clifford Costello; Samantha Seitter; Ann Lehto; Olga V Savinova; Yue-Feng Chen; A Martin Gerdes
Journal:  Front Physiol       Date:  2017-04-12       Impact factor: 4.566

Review 6.  Thyroid Hormone Signalling in Human Evolution and Disease: A Novel Hypothesis.

Authors:  Polyxeni Mantzouratou; Angelo Michele Lavecchia; Christodoulos Xinaris
Journal:  J Clin Med       Date:  2021-12-23       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.